Eureka Group Holdings Ltd

Eureka Group Holdings Ltd maintains a market capitalization of approximately AUD 248.8 million, with a price-to-earnings ratio of 12.4 and a price-to-book ratio of 1.04. The company's liquidity position is characterized by a current ratio of 0.93, indicating that its current liabilities slightly exceed its current assets. The company's cash and equivalents amount to AUD 2.8 million, while its long-term debt stands at AUD 56.7 million, resulting in a debt-to-equity ratio of 0.24. In terms of profitability, the company reports a return on equity (ROE) of 8.35% and a return on assets (ROA) of 6.03%. These figures suggest that the company is generating returns that are in line with or slightly above the industry median for similar firms. The operating margin, calculated as operating income divided by revenue, is 27.9%, which is a strong indicator of the company's ability to control costs and generate profit from its operations. The company's revenue is primarily concentrated in its core pharmaceuticals and healthcare services segment, with no significant geographic diversification reported in the available data. This concentration may expose the company to regional economic fluctuations and regulatory changes specific to its primary market. Looking ahead, the company is projected to experience a growth trajectory, with analysts providing a mean price target of AUD 0.71, which is higher than the current market price of AUD 0.58. The company's revenue has shown a positive trend, supported by its strong operating cash flow of AUD 10.8 million and free cash flow of AUD 16.5 million. These cash flow figures indicate the company's ability to fund operations, invest in growth, and potentially return value to shareholders. The risk assessment for Eureka Group Holdings Ltd highlights a medium liquidity risk, primarily due to the company's negative net cash position after accounting for total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's capital structure and financial flexibility are further supported by its relatively low debt levels and strong profitability metrics. Recent events and filings have not indicated any major operational or financial disruptions for the company. The company's financial health and strategic direction appear to be stable, with no significant negative signals reported in the latest filings or transcripts.